Peer Review reports
From: TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
| Original Submission | ||
|---|---|---|
| 28 Nov 2018 | Submitted | Original manuscript |
| 21 Dec 2018 | Reviewed | Reviewer Report - Tze-Sing Huang |
| 28 Dec 2018 | Reviewed | Reviewer Report - James J. Driscoll |
| 2 Apr 2019 | Author responded | Author comments - Louie Semaan |
| Resubmission - Version 2 | ||
| 2 Apr 2019 | Submitted | Manuscript version 2 |
| 22 Apr 2019 | Reviewed | Reviewer Report - James J. Driscoll |
| 12 May 2019 | Reviewed | Reviewer Report - Tze-Sing Huang |
| 28 Jun 2019 | Author responded | Author comments - Louie Semaan |
| Resubmission - Version 3 | ||
| 28 Jun 2019 | Submitted | Manuscript version 3 |
| 9 Aug 2019 | Author responded | Author comments - Louie Semaan |
| Resubmission - Version 4 | ||
| 9 Aug 2019 | Submitted | Manuscript version 4 |
| 28 Aug 2019 | Author responded | Author comments - Louie Semaan |
| Resubmission - Version 5 | ||
| 28 Aug 2019 | Submitted | Manuscript version 5 |
| 16 Sep 2019 | Author responded | Author comments - Louie Semaan |
| Resubmission - Version 6 | ||
| 16 Sep 2019 | Submitted | Manuscript version 6 |
| Publishing | ||
| 20 Sep 2019 | Editorially accepted | |
| 21 Oct 2019 | Article published | 10.1186/s12885-019-6185-0 |
You can find further information about peer review here.